University of Utah Health researchers have shown that a protein involved in cancer growth also plays a role in whether a ...
From increasing price transparency to curbing prescription drug costs, states are trying to figure out how to rein in rising ...
The FDA has approved Mimrylo (rusfertide) to treat adults with polycythemia vera (PV), a blood cancer that causes the overproduction of red blood cells. The excess cells thicken t ...
In theory, agentic AI’s ability to self-refine could mean improved patient outcomes. Hennessy says it also raises questions ...
Repatha (evolocumab) lowered the risk of death from any cause by 20% in high-risk adults without a previous heart attack or ...
Managed Healthcare Executive and the Pharmacy Benefit Management Institute (PBMI) are recognizing outstanding professionals in pharmacy benefits with the PBMI Innovators award. We are celebrating ...
The FDA has approved Lilly’s Mounjaro (tirzepatide) to lower the risk of major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal heart attack, or non-fatal stroke in ...
Medicare Advantage enrollees who developed a new complex condition, such as congestive heart failure or Alzheimer’s disease, were more likely to leave their plan for traditional Medicare the next year ...
The FDA has approved Lisraya (brepocitinib) to treat adults with dermatomyositis, rare autoimmune disease. Dermatomyositis ...
University of Maryland researchers used machine learning models trained on claims data of adults with diabetes to predict ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results